Trial Profile
Switching of twice a day combination regimen to once daily inhalation of fluticasone furoate (FF)/vilanterol (VI)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jan 2017
Price :
$35
*
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 03 Jan 2017 New trial record